about
Medical therapeutic agents for Wilson's diseaseCopper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 MutationsCanine Models for Copper Homeostasis DisordersRapid and reliable diagnosis of Wilson disease using X-ray fluorescence.Copper is required for oncogenic BRAF signalling and tumorigenesisGenotype-phenotype correlations in a mountain population community with high prevalence of Wilson's disease: genetic and clinical homogeneityElucidation of the ATP7B N-domain Mg2+-ATP coordination site and its allosteric regulationRetinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography.Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease.Identification of high-copper-responsive target pathways in Atp7b knockout mouse liver by GSEA on microarray data sets.Selective impairment of attentional networks of alerting in Wilson's diseaseAn optimized, chemically regulated gene expression system for Chlamydomonas.Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.Neuropareidolia: diagnostic clues apropos of visual illusions.Positron emission tomography for measurement of copper fluxes in live organisms.Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis.A functional screen for copper homeostasis genes identifies a pharmacologically tractable cellular system.Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson's disease: a resting-state fMRI studyDemonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat ModelClinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations.Comparative assessment of clinical rating scales in Wilson's disease.Proteomic analysis of the hepatic tissue of Long-Evans Cinnamon (LEC) rats according to the natural course of Wilson disease.A prochelator with a modular masking group featuring hydrogen peroxide activation with concurrent fluorescent reportingFulminant Wilson's Disease Managed with Plasmapheresis as a Bridge to Liver TransplantEndogenous formation and repair of oxidatively induced G[8-5 m]T intrastrand cross-link lesion.Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study.Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.Evidence for synergistic effects of PRNP and ATP7B mutations in severe neuropsychiatric deterioration.Visualization of copper metabolism by 64CuCl₂-PET.Clinical presentation and mutations in Danish patients with Wilson disease.1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.Wilson's disease: a comprehensive review of the molecular mechanisms.Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.Pharmacological activity of metal binding agents that alter copper bioavailability.Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson diseaseLiver transplantation for Wilson disease.Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, IranProtective Effects of D-Penicillamine on Catecholamine-Induced Myocardial InjuryOptical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease
P2860
Q24236053-8754B5EB-072E-4373-AE3C-EF1E504BAFE4Q26748245-796B5615-2F8A-4098-9BF5-16204C5A214AQ26767292-935E4EF4-BA4C-4678-A36E-57368A9BD383Q27338256-D08C57DD-B2F1-4AA3-B291-3155C8B67C98Q28237892-1DC21155-6129-4D2A-8571-CE9F12E50A91Q28539339-2FCDF530-648A-42DD-84FC-DD5E56D05E4FQ28743427-CF42B0B3-2914-4609-A23E-CE10A8611B38Q30460735-16EABF90-E923-4C5E-A3C0-DB4EBA2AEF51Q30558701-C0721A7F-5EE1-4D3D-AA42-316B1EEF722DQ31035638-E1676C61-F305-4AEC-9A52-78F44987D1B5Q31166656-248E8E66-AE7E-46A4-892F-E2AD67F288B3Q33369095-31891D64-EE4B-4B1A-A154-427C73B27686Q33411048-F1461AC0-2446-4353-AD2C-7233E065C82BQ33523533-00D3A9CC-2FA8-4400-800C-9503946FC5FFQ33610789-D54B376B-C88D-47E1-AD8E-65EB1B7E85BEQ33618006-343BA1D6-035E-4171-9813-9342D3FB94DAQ33622307-9AB15077-6622-4955-AC78-A999ABF15D19Q33639391-872919E4-7AAB-4477-B144-D6428BE27C5DQ33763218-0EAD5A08-EBBD-457C-97A2-10E4232726A4Q33789624-8885DC7F-4536-4605-9FF2-93A4841A1FC7Q33922873-423ADC5F-91D5-4DBC-AF62-764757A169A1Q33959613-B2C9E47D-A2BA-48F5-B4D9-D345B9AF825CQ34132325-3D36A9C8-EBC8-40BA-82BE-C7DDFD0BF9D7Q34243046-4E36DB08-70BE-418F-8798-1889566F1A46Q34267490-7E030A15-6D59-450B-84BD-831F0E29CD0AQ34438061-99FDED10-D77B-4FC9-96FE-093C8D9F43B8Q34529088-855EA631-3139-45A9-A761-83DC562973B1Q34544874-67C97001-8E50-46F4-89D5-7275A308717DQ35098831-5FA09718-921B-4A47-BC28-C2BBC7BF61FFQ35161173-9E16DFDD-0535-49E6-92CE-AABE295C802AQ35230120-41277B5C-9D43-4EE6-8A71-2D81D6A5C095Q35300486-15FECF0C-93A8-4B7A-9D65-B28F8B232ED1Q35381754-D4D4CF16-8D19-494F-A159-489921A72F0EQ35391010-E2FB169D-CD8E-4F9D-89D3-4F5445741604Q35587484-9C14C9FB-FFA6-4442-B37C-5E7593551F7FQ35594074-854C0397-6BC5-4008-8412-D0AA65874CA7Q35736533-840C1FDA-AA62-4D4C-AA2B-509D491BD1ECQ36216217-5816AE38-47E4-4C85-8D99-F3651B4F4252Q36405689-7A3F0408-9F8B-4938-B7F1-38D971BACE4EQ36686111-3AF3CBA1-5418-4C5B-9E94-F23AB86C4BF0
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
наукова стаття, опублікована в лютому 2007
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Wilson's disease
@en
type
label
Wilson's disease
@en
prefLabel
Wilson's disease
@en
P2093
P1433
P1476
Wilson's disease
@en
P2093
Ann P Walker
James S Dooley
Keyoumars Ashkan
Michael L Schilsky
P304
P356
10.1016/S0140-6736(07)60196-2
P407
P50
P577
2007-02-01T00:00:00Z